A phase II study of epratuzumab and rituximab in combination with cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy (ER-CHOP) in patients with previously untreated diffuse large B-cell lymphoma

Ivana Micallef,Matthew J. Maurer,Daniel A. Nikcevich,Michael W. Cannon,Dennis F. Moore,Paul J. Kurtin,T.E. Witzig

A phase II study of epratuzumab and rituximab in combination with cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy (ER-CHOP) in patients with previously untreated diffuse large B-cell lymphoma

2008

Ivana Micallef
Matthew J. Maurer
Daniel A. Nikcevich
Michael W. Cannon
Dennis F. Moore
Paul J. Kurtin
T.E. Witzig

8500 Background: A prior pilot study of epratuzumab and rituximab in combination with cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy (ER-CHOP) in untreated patients with dif...

Keywords:

Cyclophosphamide/doxorubicin/vincristine
Rituximab
Pathology
Epratuzumab
Diffuse large B-cell lymphoma
CHOP
Phases of clinical research
Cancer research
Medicine
Prednisone chemotherapy
Doxorubicin
Vincristine
Oncology
Internal medicine
Cyclophosphamide

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations